Cargando…

PET imaging of hepatocellular carcinoma with anti-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in comparison with l-[S-methyl-(11)C]methionine

PURPOSE: [(11)C]methionine ([(11)C]Met) was used for cancer imaging based on upregulated amino acid transport and protein synthesis in different tumor types. However, the short half-life of (11)C decay limited further clinical development of [(11)C]Met. Synthetic amino acid analog anti-1-amino-3-[(1...

Descripción completa

Detalles Bibliográficos
Autores principales: Sergeeva, Olga, Zhang, Yifan, Kenyon, Jonathan D., Miller-Atkins, Galen A., Wu, Chunying, Iyer, Renuka, Sexton, Sandra, Wojtylak, Patrick, Awadallah, Amad, Xin, Wei, Chan, E. Ricky, O’Donnel, James K., Lee, Zhenghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531569/
https://www.ncbi.nlm.nih.gov/pubmed/31119488
http://dx.doi.org/10.1186/s13550-019-0519-4
_version_ 1783420859847802880
author Sergeeva, Olga
Zhang, Yifan
Kenyon, Jonathan D.
Miller-Atkins, Galen A.
Wu, Chunying
Iyer, Renuka
Sexton, Sandra
Wojtylak, Patrick
Awadallah, Amad
Xin, Wei
Chan, E. Ricky
O’Donnel, James K.
Lee, Zhenghong
author_facet Sergeeva, Olga
Zhang, Yifan
Kenyon, Jonathan D.
Miller-Atkins, Galen A.
Wu, Chunying
Iyer, Renuka
Sexton, Sandra
Wojtylak, Patrick
Awadallah, Amad
Xin, Wei
Chan, E. Ricky
O’Donnel, James K.
Lee, Zhenghong
author_sort Sergeeva, Olga
collection PubMed
description PURPOSE: [(11)C]methionine ([(11)C]Met) was used for cancer imaging based on upregulated amino acid transport and protein synthesis in different tumor types. However, the short half-life of (11)C decay limited further clinical development of [(11)C]Met. Synthetic amino acid analog anti-1-amino-3-[(18)F]fluoro-cyclobutyl-1-carboxylic acid ([(18)F]FCABC) was developed and FDA-approved for PET imaging of recurrent prostate cancer. This study investigated “repurposed” [(18)F]FACBC for PET imaging of primary liver cancer such as hepatocellular carcinoma (HCC) in comparison with [(11)C]Met. METHODS: [(11)C]Met was synthesized in the lab, and [(18)F]FACBC was purchased from a commercial outlet. A clinically relevant animal model of spontaneously developed HCC in the woodchucks was used for PET imaging. Bioinformatics analysis was performed for the expression of amino acid transporters responsible for radiotracer uptake and validated by PCR. Dynamic PET scans of [(11)C]Met and [(18)F]FACBC were acquired within 1 week. Standardized uptake value (SUV) was calculated for regions of interest (ROIs) defined over HCC and a liver background region. H&E staining and immunohistochemical (IHC) staining were performed with harvested tissues post-imaging. RESULTS: Higher expression of ACST2 and LAT1 was found in HCC than in the surrounding liver tissues. PCR validated this differential expression. [(11)C]Met and [(18)F]FACBC displayed some differences in their uptake and retention in HCC. Both peaked in HCC with an SUV of 3.5 after 10 min post-injection. Met maintained a plateaued contrast uptake in HCC to that in the liver while [(18)F]FCABC declined in HCC and liver after peak uptake. The pathological assessment revealed the liver tumor as moderately differentiated similar to the human HCC and proliferative. CONCLUSION: Both [(18)F]FACBC and [(11)C]Met showed uptake in HCC through the use of a clinically relevant animal model of woodchuck HCC. The uptake and retention of [(18)F]FACBC and [(11)C]Met depend on their metabolism and also rely on the distribution of their principal amino acid transporters.
format Online
Article
Text
id pubmed-6531569
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-65315692019-06-07 PET imaging of hepatocellular carcinoma with anti-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in comparison with l-[S-methyl-(11)C]methionine Sergeeva, Olga Zhang, Yifan Kenyon, Jonathan D. Miller-Atkins, Galen A. Wu, Chunying Iyer, Renuka Sexton, Sandra Wojtylak, Patrick Awadallah, Amad Xin, Wei Chan, E. Ricky O’Donnel, James K. Lee, Zhenghong EJNMMI Res Original Research PURPOSE: [(11)C]methionine ([(11)C]Met) was used for cancer imaging based on upregulated amino acid transport and protein synthesis in different tumor types. However, the short half-life of (11)C decay limited further clinical development of [(11)C]Met. Synthetic amino acid analog anti-1-amino-3-[(18)F]fluoro-cyclobutyl-1-carboxylic acid ([(18)F]FCABC) was developed and FDA-approved for PET imaging of recurrent prostate cancer. This study investigated “repurposed” [(18)F]FACBC for PET imaging of primary liver cancer such as hepatocellular carcinoma (HCC) in comparison with [(11)C]Met. METHODS: [(11)C]Met was synthesized in the lab, and [(18)F]FACBC was purchased from a commercial outlet. A clinically relevant animal model of spontaneously developed HCC in the woodchucks was used for PET imaging. Bioinformatics analysis was performed for the expression of amino acid transporters responsible for radiotracer uptake and validated by PCR. Dynamic PET scans of [(11)C]Met and [(18)F]FACBC were acquired within 1 week. Standardized uptake value (SUV) was calculated for regions of interest (ROIs) defined over HCC and a liver background region. H&E staining and immunohistochemical (IHC) staining were performed with harvested tissues post-imaging. RESULTS: Higher expression of ACST2 and LAT1 was found in HCC than in the surrounding liver tissues. PCR validated this differential expression. [(11)C]Met and [(18)F]FACBC displayed some differences in their uptake and retention in HCC. Both peaked in HCC with an SUV of 3.5 after 10 min post-injection. Met maintained a plateaued contrast uptake in HCC to that in the liver while [(18)F]FCABC declined in HCC and liver after peak uptake. The pathological assessment revealed the liver tumor as moderately differentiated similar to the human HCC and proliferative. CONCLUSION: Both [(18)F]FACBC and [(11)C]Met showed uptake in HCC through the use of a clinically relevant animal model of woodchuck HCC. The uptake and retention of [(18)F]FACBC and [(11)C]Met depend on their metabolism and also rely on the distribution of their principal amino acid transporters. Springer Berlin Heidelberg 2019-05-22 /pmc/articles/PMC6531569/ /pubmed/31119488 http://dx.doi.org/10.1186/s13550-019-0519-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research
Sergeeva, Olga
Zhang, Yifan
Kenyon, Jonathan D.
Miller-Atkins, Galen A.
Wu, Chunying
Iyer, Renuka
Sexton, Sandra
Wojtylak, Patrick
Awadallah, Amad
Xin, Wei
Chan, E. Ricky
O’Donnel, James K.
Lee, Zhenghong
PET imaging of hepatocellular carcinoma with anti-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in comparison with l-[S-methyl-(11)C]methionine
title PET imaging of hepatocellular carcinoma with anti-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in comparison with l-[S-methyl-(11)C]methionine
title_full PET imaging of hepatocellular carcinoma with anti-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in comparison with l-[S-methyl-(11)C]methionine
title_fullStr PET imaging of hepatocellular carcinoma with anti-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in comparison with l-[S-methyl-(11)C]methionine
title_full_unstemmed PET imaging of hepatocellular carcinoma with anti-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in comparison with l-[S-methyl-(11)C]methionine
title_short PET imaging of hepatocellular carcinoma with anti-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in comparison with l-[S-methyl-(11)C]methionine
title_sort pet imaging of hepatocellular carcinoma with anti-1-amino-3-[(18)f]fluorocyclobutanecarboxylic acid in comparison with l-[s-methyl-(11)c]methionine
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531569/
https://www.ncbi.nlm.nih.gov/pubmed/31119488
http://dx.doi.org/10.1186/s13550-019-0519-4
work_keys_str_mv AT sergeevaolga petimagingofhepatocellularcarcinomawithanti1amino318ffluorocyclobutanecarboxylicacidincomparisonwithlsmethyl11cmethionine
AT zhangyifan petimagingofhepatocellularcarcinomawithanti1amino318ffluorocyclobutanecarboxylicacidincomparisonwithlsmethyl11cmethionine
AT kenyonjonathand petimagingofhepatocellularcarcinomawithanti1amino318ffluorocyclobutanecarboxylicacidincomparisonwithlsmethyl11cmethionine
AT milleratkinsgalena petimagingofhepatocellularcarcinomawithanti1amino318ffluorocyclobutanecarboxylicacidincomparisonwithlsmethyl11cmethionine
AT wuchunying petimagingofhepatocellularcarcinomawithanti1amino318ffluorocyclobutanecarboxylicacidincomparisonwithlsmethyl11cmethionine
AT iyerrenuka petimagingofhepatocellularcarcinomawithanti1amino318ffluorocyclobutanecarboxylicacidincomparisonwithlsmethyl11cmethionine
AT sextonsandra petimagingofhepatocellularcarcinomawithanti1amino318ffluorocyclobutanecarboxylicacidincomparisonwithlsmethyl11cmethionine
AT wojtylakpatrick petimagingofhepatocellularcarcinomawithanti1amino318ffluorocyclobutanecarboxylicacidincomparisonwithlsmethyl11cmethionine
AT awadallahamad petimagingofhepatocellularcarcinomawithanti1amino318ffluorocyclobutanecarboxylicacidincomparisonwithlsmethyl11cmethionine
AT xinwei petimagingofhepatocellularcarcinomawithanti1amino318ffluorocyclobutanecarboxylicacidincomparisonwithlsmethyl11cmethionine
AT chanericky petimagingofhepatocellularcarcinomawithanti1amino318ffluorocyclobutanecarboxylicacidincomparisonwithlsmethyl11cmethionine
AT odonneljamesk petimagingofhepatocellularcarcinomawithanti1amino318ffluorocyclobutanecarboxylicacidincomparisonwithlsmethyl11cmethionine
AT leezhenghong petimagingofhepatocellularcarcinomawithanti1amino318ffluorocyclobutanecarboxylicacidincomparisonwithlsmethyl11cmethionine